Annual SGA
$49.47 M
-$20.61 M-29.40%
June 30, 2024
Summary
- As of February 8, 2025, AYTU annual SGA is $49.47 million, with the most recent change of -$20.61 million (-29.40%) on June 30, 2024.
- During the last 3 years, AYTU annual SGA has fallen by -$6.34 million (-11.35%).
- AYTU annual SGA is now -29.40% below its all-time high of $70.08 million, reached on June 30, 2023.
Performance
AYTU SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly SGA
$10.78 M
-$304.00 K-2.74%
September 30, 2024
Summary
- As of February 8, 2025, AYTU quarterly SGA is $10.78 million, with the most recent change of -$304.00 thousand (-2.74%) on September 30, 2024.
- Over the past year, AYTU quarterly SGA has dropped by -$1.60 million (-12.93%).
- AYTU quarterly SGA is now -47.98% below its all-time high of $20.73 million, reached on June 30, 2021.
Performance
AYTU Quarterly SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM SGA
-$1.27 B
-$6.25 M-0.50%
September 30, 2024
Summary
- As of February 8, 2025, AYTU TTM SGA is -$1.27 billion, with the most recent change of -$6.25 million (-0.50%) on September 30, 2024.
- Over the past year, AYTU TTM SGA has dropped by -$1.33 billion (-2046.95%).
- AYTU TTM SGA is now -63314750.00% below its all-time high of -$2000.00.
Performance
AYTU TTM SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Selling, General & Administrative Expenses Formula
SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development
AYTU Selling, General & Administrative Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -29.4% | -12.9% | -2047.0% |
| 3 y3 years | -11.3% | -38.4% | -2138.1% |
| 5 y5 years | +157.1% | -14.4% | -2811.6% |
AYTU Selling, General & Administrative Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -29.4% | at low | -46.0% | at low | -66.3% | at low |
| 5 y | 5-year | -29.4% | +157.1% | -48.0% | +65.5% | -200.7% | at low |
| alltime | all time | -29.4% | >+9999.0% | -48.0% | >+9999.0% | <-9999.0% | at low |
Aytu BioPharma Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $10.78 M(-2.7%) | $45.88 M(-3.4%) |
| Jun 2024 | $49.47 M(-29.4%) | $11.09 M(-7.5%) | $47.48 M(-6.0%) |
| Mar 2024 | - | $11.99 M(-0.2%) | $50.49 M(-13.7%) |
| Dec 2023 | - | $12.02 M(-3.0%) | $58.48 M(-10.1%) |
| Sep 2023 | - | $12.39 M(-12.1%) | $65.04 M(-7.2%) |
| Jun 2023 | $70.08 M(+0.3%) | $14.10 M(-29.5%) | $70.08 M(-4.5%) |
| Mar 2023 | - | $19.98 M(+7.6%) | $73.38 M(+3.7%) |
| Dec 2022 | - | $18.58 M(+6.6%) | $70.76 M(+1.4%) |
| Sep 2022 | - | $17.42 M(+0.2%) | $69.79 M(-0.1%) |
| Jun 2022 | $69.88 M(+25.2%) | $17.39 M(+0.2%) | $69.88 M(-4.6%) |
| Mar 2022 | - | $17.36 M(-1.4%) | $73.22 M(+7.0%) |
| Dec 2021 | - | $17.61 M(+0.6%) | $68.46 M(+10.2%) |
| Sep 2021 | - | $17.51 M(-15.5%) | $62.13 M(+11.2%) |
| Jun 2021 | $55.81 M(+79.7%) | $20.73 M(+64.6%) | $55.87 M(+19.6%) |
| Mar 2021 | - | $12.60 M(+11.6%) | $46.70 M(+7.9%) |
| Dec 2020 | - | $11.29 M(+0.4%) | $43.29 M(+12.4%) |
| Sep 2020 | - | $11.25 M(-2.8%) | $38.52 M(+18.8%) |
| Jun 2020 | $31.06 M(+61.4%) | $11.57 M(+25.8%) | $32.42 M(+25.9%) |
| Mar 2020 | - | $9.19 M(+41.0%) | $25.75 M(+17.4%) |
| Dec 2019 | - | $6.52 M(+26.6%) | $21.93 M(+6.7%) |
| Sep 2019 | - | $5.15 M(+5.1%) | $20.56 M(+6.8%) |
| Jun 2019 | $19.24 M(+8.5%) | $4.90 M(-8.9%) | $19.24 M(+5.3%) |
| Mar 2019 | - | $5.38 M(+4.6%) | $18.27 M(+4.2%) |
| Dec 2018 | - | $5.14 M(+34.1%) | $17.53 M(+3.4%) |
| Sep 2018 | - | $3.83 M(-2.4%) | $16.94 M(-4.4%) |
| Jun 2018 | $17.73 M(+0.7%) | $3.92 M(-15.4%) | $17.73 M(+1.1%) |
| Mar 2018 | - | $4.64 M(+1.9%) | $17.55 M(+1.3%) |
| Dec 2017 | - | $4.55 M(-1.4%) | $17.33 M(+5.2%) |
| Sep 2017 | - | $4.62 M(+23.5%) | $16.47 M(-6.5%) |
| Jun 2017 | $17.61 M(+99.5%) | $3.74 M(-15.4%) | $17.61 M(+3.4%) |
| Mar 2017 | - | $4.42 M(+19.7%) | $17.02 M(+14.7%) |
| Dec 2016 | - | $3.69 M(-35.8%) | $14.85 M(+14.8%) |
| Sep 2016 | - | $5.76 M(+82.5%) | $12.93 M(+45.6%) |
| Jun 2016 | $8.82 M(+105.6%) | $3.15 M(+40.5%) | $8.88 M(+26.3%) |
| Mar 2016 | - | $2.25 M(+26.6%) | $7.03 M(+19.7%) |
| Dec 2015 | - | $1.77 M(+3.8%) | $5.88 M(+42.5%) |
| Sep 2015 | - | $1.71 M(+31.0%) | $4.12 M(+70.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2015 | $4.29 M(+7907.5%) | $1.30 M(+19.9%) | $2.42 M(+114.5%) |
| Mar 2015 | - | $1.09 M(>+9900.0%) | $1.13 M(+2609.1%) |
| Feb 2015 | - | $8400.00(-38.2%) | $41.70 K(-21.8%) |
| Nov 2014 | - | $13.60 K(+60.0%) | $53.30 K(-0.6%) |
| Aug 2014 | $53.60 K(-97.7%) | $8500.00(-24.1%) | $53.60 K(+0.2%) |
| Jun 2014 | $2.35 M(+4788.8%) | - | - |
| May 2014 | - | $11.20 K(-44.0%) | $53.50 K(-0.7%) |
| Feb 2014 | - | $20.00 K(+43.9%) | $53.90 K(+18.7%) |
| Nov 2013 | - | $13.90 K(+65.5%) | $45.40 K(-5.4%) |
| Aug 2013 | $48.00 K(-5.5%) | $8400.00(-27.6%) | $48.00 K(-13.2%) |
| May 2013 | - | $11.60 K(+0.9%) | $55.30 K(+4.3%) |
| Feb 2013 | - | $11.50 K(-30.3%) | $53.00 K(+6.0%) |
| Nov 2012 | - | $16.50 K(+5.1%) | $50.00 K(-4.6%) |
| Aug 2012 | $50.80 K(-62.0%) | $15.70 K(+68.8%) | $52.40 K(-51.2%) |
| May 2012 | - | $9300.00(+9.4%) | $107.40 K(-9.1%) |
| Feb 2012 | - | $8500.00(-55.0%) | $118.10 K(-13.1%) |
| Nov 2011 | - | $18.90 K(-73.3%) | $135.90 K(+1.7%) |
| Aug 2011 | $133.60 K(+146.5%) | $70.70 K(+253.5%) | $133.60 K(+82.0%) |
| May 2011 | - | $20.00 K(-24.0%) | $73.40 K(+9.2%) |
| Feb 2011 | - | $26.30 K(+58.4%) | $67.20 K(+28.7%) |
| Nov 2010 | - | $16.60 K(+58.1%) | $52.20 K(-3.5%) |
| Aug 2010 | $54.20 K(-1.3%) | $10.50 K(-23.9%) | $54.10 K(+5.5%) |
| May 2010 | - | $13.80 K(+22.1%) | $51.30 K(+6.9%) |
| Feb 2010 | - | $11.30 K(-38.9%) | $48.00 K(-7.3%) |
| Nov 2009 | - | $18.50 K(+140.3%) | $51.80 K(-5.5%) |
| Aug 2009 | $54.90 K(+7.4%) | $7700.00(-26.7%) | $54.80 K(-0.4%) |
| May 2009 | - | $10.50 K(-30.5%) | $55.00 K(-11.0%) |
| Feb 2009 | - | $15.10 K(-29.8%) | $61.80 K(+7.9%) |
| Nov 2008 | - | $21.50 K(+172.2%) | $57.30 K(+12.4%) |
| Aug 2008 | $51.10 K(+9.0%) | $7900.00(-54.3%) | $51.00 K(-6.1%) |
| May 2008 | - | $17.30 K(+63.2%) | $54.30 K(+7.1%) |
| Feb 2008 | - | $10.60 K(-30.3%) | $50.70 K(-8.0%) |
| Nov 2007 | - | $15.20 K(+35.7%) | $55.10 K(+17.5%) |
| Aug 2007 | $46.90 K | $11.20 K(-18.2%) | $46.90 K(+31.4%) |
| May 2007 | - | $13.70 K(-8.7%) | $35.70 K(+49.4%) |
| Feb 2007 | - | $15.00 K(+114.3%) | $23.90 K(+168.5%) |
| Nov 2006 | - | $7000.00(+268.4%) | $8900.00(+368.4%) |
| May 2006 | - | $1900.00 | $1900.00 |
FAQ
- What is Aytu BioPharma annual SGA?
- What is the all time high annual SGA for Aytu BioPharma?
- What is Aytu BioPharma annual SGA year-on-year change?
- What is Aytu BioPharma quarterly SGA?
- What is the all time high quarterly SGA for Aytu BioPharma?
- What is Aytu BioPharma quarterly SGA year-on-year change?
- What is Aytu BioPharma TTM SGA?
- What is the all time high TTM SGA for Aytu BioPharma?
- What is Aytu BioPharma TTM SGA year-on-year change?
What is Aytu BioPharma annual SGA?
The current annual SGA of AYTU is $49.47 M
What is the all time high annual SGA for Aytu BioPharma?
Aytu BioPharma all-time high annual SGA is $70.08 M
What is Aytu BioPharma annual SGA year-on-year change?
Over the past year, AYTU annual SGA has changed by -$20.61 M (-29.40%)
What is Aytu BioPharma quarterly SGA?
The current quarterly SGA of AYTU is $10.78 M
What is the all time high quarterly SGA for Aytu BioPharma?
Aytu BioPharma all-time high quarterly SGA is $20.73 M
What is Aytu BioPharma quarterly SGA year-on-year change?
Over the past year, AYTU quarterly SGA has changed by -$1.60 M (-12.93%)
What is Aytu BioPharma TTM SGA?
The current TTM SGA of AYTU is -$1.27 B
What is the all time high TTM SGA for Aytu BioPharma?
Aytu BioPharma all-time high TTM SGA is -$2000.00
What is Aytu BioPharma TTM SGA year-on-year change?
Over the past year, AYTU TTM SGA has changed by -$1.33 B (-2046.95%)